D-dimer levels predict the treatment efficacy and prognosis of esophageal squamous cell carcinoma treated with PD-1/PD-L1 inhibitors
The International Journal of Biological Markers · 2024-08 · 39 (3) · 209-216
DOI: 10.1177/03936155241262045 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biological Markers, online erschienen am 17.06.2024. Verfasst von Yuchen Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhejiang Cancer Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Fibrin Fibrinogen Degradation Products, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Objectives
This study aimed to explore the value of D-dimer levels in predicting the treatment efficacy and prognosis of advanced esophageal squamous cell carcinoma (ESCC) treated with programmed cell death protein-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors.
Methods
The study retrospectively analyzed 233 ESCC patients who received PD-1/PD-L1 inhibitors. The optimal cut-off values for platelets, fibrinogen, and D-dimer were calculated based on maximally selected rank statistics for patients’ overall survival. Univariate and multivariate analyses of progression-free survival and overall survival were conducted by Cox proportional hazards regression model. Subgroup analyses of D-dimer levels in different fibrinogen levels were performed by log-rank test.
Results
The multivariate Cox regression analyses demonstrated that ESCC patients with D-dimer levels > 236 ng/mL exhibited both poorer progression-free survival ( P = 0.004) and overall survival ( P < 0.0001) compared to those with low D-dimer levels. The subgroup analyses further indicated that in the group of low fibrinogen levels, the higher D-dimer levels of ESCC patients exhibited significantly shorter progression-free survival ( P = 0.0021) and overall survival ( P < 0.0001).
Conclusions
The study revealed that the D-dimer levels possess predictive value for the treatment efficacy and prognosis of ESCC patients treated with PD-1/PD-L1 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Zhejiang Cancer Hospital, Hangzhou, China.
- Department of Respiratory, Yichun Central Hospital, Yichun, China.
- Postgraduate Training Base Alliance, Wenzhou Medical University, Wenzhou, China.
- Department of Oncological Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
ORCID-Profile: Yuchen Wu
Förderung
- The Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Wu, Y., Liu, X., Li, H., Wang, W., Ye, L., Zhou, Y., & Chen, D. (2024). D-dimer levels predict the treatment efficacy and prognosis of esophageal squamous cell carcinoma treated with PD-1/PD-L1 inhibitors. The International Journal of Biological Markers, 39(3), 209-216. https://doi.org/10.1177/03936155241262045
Vancouver
Wu Y, Liu X, Li H, Wang W, Ye L, Zhou Y, et al. D-dimer levels predict the treatment efficacy and prognosis of esophageal squamous cell carcinoma treated with PD-1/PD-L1 inhibitors. The International Journal of Biological Markers. 2024;39(3):209-216. doi:10.1177/03936155241262045
BibTeX
@article{Wu2024,
author = {Wu, Yuchen and Liu, Xin and Li, Huihui and Wang, Wenjing and Ye, Lisha and Zhou, Yun and Chen, Da},
title = {D-dimer levels predict the treatment efficacy and prognosis of esophageal squamous cell carcinoma treated with PD-1/PD-L1 inhibitors},
journal = {The International Journal of Biological Markers},
year = {2024},
volume = {39},
number = {3},
pages = {209--216},
doi = {10.1177/03936155241262045}
}
EUVIMED